VALEANT INTL
Big PharmaVALEANT INTL is a major pharmaceutical company focused on Dermatology, Immunology, Gastroenterology.
VALEANT INTL's Key Drugs
VALEANT INTL's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
VALEANT INTL's Recent FDA Approvals
New NDA/BLA approvals for VALEANT INTL over the last two years — novel drugs only, excluding generics and label supplements.
VALEANT INTL's Therapeutic Areas
VALEANT INTL's approved drugs and pipeline span 3 therapeutic areas, led by Dermatology and Immunology, across 0 biologic and 3 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
VALEANT INTL's Top Competitors
VALEANT INTL's closest competitors by therapeutic-area and drug-target overlap include BAUSCH, APOTHECON, and Pfizer. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
VALEANT INTL Pipeline Snapshot
Active clinical trials for VALEANT INTL across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Dermatology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1952-11-10
- Latest
- 2016-12-16
- Applications
- 40